Gilead posts 16% base business sales growth as HIV jumps to $6.2B and Trodelvy rises 42%
Market Chameleon (Fri, 30-Oct 7:11 AM)
Needham Sticks to Their Buy Rating for Gilead Sciences (GILD)
at www.tipranks.com (Fri, 30-Oct 7:49 AM)
Gilead widens 2026 non-GAAP loss forecast despite Q3 beats
at seekingalpha.com (Thu, 29-Oct 5:09 PM)
Gilead Sciences Non-GAAP EPS of $2.55 beats by $0.36, revenue of $8.3B beats by $500M
at seekingalpha.com (Thu, 29-Oct 4:05 PM)
Here are the major earnings after the close Thursday
at seekingalpha.com (Thu, 29-Oct 10:00 AM)
Gilead Sciences Q3 2026 Earnings Preview
at seekingalpha.com (Wed, 28-Oct 12:41 PM)
at www.tipranks.com (Wed, 28-Oct 9:40 AM)
Gilead Sciences (GILD) Gets a Hold from Robert W. Baird
at www.tipranks.com (Wed, 28-Oct 2:45 AM)
Options Volatility and Implied Earnings Moves This Week, October 26 – October 30, 2026
at www.tipranks.com (Mon, 26-Oct 8:01 AM)
Gilead Sciences (GILD) Receives a Buy from Bernstein
at www.tipranks.com (Mon, 26-Oct 6:39 AM)
Earnings Week Ahead: MSFT, GOOGL, AMZN, XOM, BA, VZ, and more
at seekingalpha.com (Sun, 25-Oct 8:07 AM)
